Updated Jul 16, 2026
Troupin Barbara has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Barbara Troupin is referenced in SEC filings associated with Equillium, Inc. as of May 29, 2026. The available context does not specify a formal title or biographical details beyond affiliation with Equillium. Equillium is a biotechnology company focused on developing therapies for autoimmune diseases. No widely published public biography or profile for Barbara Troupin is readily available in major biographical sources.
| Role | Insider |
|---|---|
| Notability | 20/100 |
Barbara Troupin is referenced in SEC filings associated with Equillium, Inc. as of May 29, 2026. The available context does not specify a formal title or biographical details beyond affiliation with Equillium. Equillium is a biotechnology company focused on developing therapies for autoimmune diseases. No widely published public biography or profile for Barbara Troupin is readi…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Troupin Barbara profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.